The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
A Randomized Trial of a Single Bolus Dosage Regimen of Recombinant Tissue Plasminogen Activator in Patients with Acute Pulmonary Embolism
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Methods for Rates and Proportions
Fleiss, J. L., Levin, B., & Paik, M. C. (2003) · Wiley Series in Probability and Statistics · doi:10.1002/0471445428 · Cited by 18,646
Applied Regression Analysis and Other Multivariable Methods
Walker, E. (1989) · Technometrics · doi:10.1080/00401706.1989.10488486 · Cited by 8,538
Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens
Clauss, A. (1957) · Acta Haematologica · doi:10.1159/000205234 · Cited by 3,208
The Thrombolysis in Myocardial Infarction (TIMI) Trial: Phase I Findings
The TIMI Study Group* (1985) · New England Journal of Medicine · doi:10.1056/nejm198504043121437 · Cited by 3,188
Applied Regression Analysis and Other Multivariable Methods.
Bhattacharyya, H. T., Kleinbaum, D. G., & Kupper, L. L. (1979) · Journal of the American Statistical Association · doi:10.2307/2287012 · Cited by 1,749
Statistical Methods for Rates and Proportions.
Plewis, I., & Fleiss, J. L. (1982) · Journal of the Royal Statistical Society. Series A (General) · doi:10.2307/2982107 · Cited by 1,731
Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin.
Hoylaerts, M., Rijken, D. C., Lijnen, H. R., & Collen, D. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)81051-7 · Cited by 1,312
Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli
Pennica, D., Holmes, W. E., Kohr, W. J., Harkins, R. N., Vehar, G. A., Ward, C. A., Bennett, W. F., Yelverton, E., Seeburg, P. H., Heyneker, H. L., et al. (1983) · Nature · doi:10.1038/301214a0 · Cited by 1,243
TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTION
Wilcox, R. G., Olsson, C. G., Skene, A. M., Von Der Lippe, G., Jensen, G., Hampton, J. R., & For The Asset Study Group (1988) · The Lancet · doi:10.1016/s0140-6736(88)92656-6 · Cited by 1,153
Verstraete, M., Bory, M., Collen, D., Erbel, R., Lennane, R. J., Mathey, D., Michels, H. R., Schartl, M., Uebis, R., Bernard, R., et al. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92208-1 · Cited by 750
Research works printed but not linked: 10
- 1970, Phase I results, JAMA, 214, 2163
- 1974, Phase II results, JAMA, 229, 1606
- Goldhaber, 1986, Acute pulmonary embolism treated with tissue plasminogen activator, Lancet, 2, 886, 10.1016/S0140-6736(86)90411-3 · doi:10.1016/s0140-6736(86)90411-3
- Agnelli, 1985, Sustained thrombolysis with DNA-recombinant tissue-type plasminogen activator in rabbits, Blood, 66, 399, 10.1182/blood.V66.2.399.399 · doi:10.1182/blood.v66.2.399.399
- Shiffman, 1988, Treatment of canine embolic pulmonary hypertension with recombinant tissue plasminogen activator. Efficacy of dosing regimens, Circulation, 19, 214, 10.1161/01.CIR.78.1.214 · doi:10.1161/01.cir.78.1.214
- 1973, Perfusion lung scanning, Circulation, 47, 46
- Parker, 1988, Pulmonary perfusion after rt-PA therapy for actue embolism: early improvement assessed with segmental perfusion scanning, Radiology, 166, 441, 10.1148/radiology.166.2.3122266 · doi:10.1148/radiology.166.2.3122266
- Verstraete, 1989, Bolus alteplase, Lancet, 2, 989, 10.1016/S0140-6736(89)91004-0 · doi:10.1016/s0140-6736(89)91004-0
- Tebbe, 1989, Single bolus injection of recombinant tissue-type plasminogen activator (rt-PA) in acute myocardial infarction, Am J Cardiol, 64, 448, 10.1016/0002-9149(89)90419-0 · doi:10.1016/0002-9149(89)90419-0
- Smalling, 1990, Improved infarct-related arterial patency after high dose, weight-adjusted, rapid infusion of tissue-type plasminogen activator in myocardial infarction. Results of a multicentre randomized trial of two dosage regimens, J Am Coll Cardiol, 15, 915, 10.1016/0735-1097(90)90216-C · doi:10.1016/0735-1097(90)90216-c
Cited by
Kearon (2012) · doi:10.1378/chest.11-2301 · Cited by 6,119
Antithrombotic Therapy for VTE Disease
Kearon, C., Akl, E. A., Ornelas, J., Blaivas, A., Jimenez, D., Bounameaux, H., Huisman, M., King, C. S., Morris, T. A., Sood, N., et al. (2016) · Chest · doi:10.1016/j.chest.2015.11.026 · Cited by 4,830
Guidelines on the diagnosis and management of acute pulmonary embolism
Authors/Task Force Members, Torbicki, A., Perrier, A., Konstantinides, S., Agnelli, G., Galiè, N., Pruszczyk, P., Bengel, F., Brady, A. J. B., Ferreira, D., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn310 · Cited by 2,826
Jaff, M. R., McMurtry, M. S., Archer, S. L., Cushman, M., Goldenberg, N., Goldhaber, S. Z., Jenkins, J. S., Kline, J. A., Michaels, A. D., Thistlethwaite, P., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318214914f · Cited by 2,229
Antithrombotic Therapy for Venous Thromboembolic Disease
Hyers, T. M., Agnelli, G., Hull, R. D., Morris, T. A., Samama, M., Tapson, V., & Weg, J. G. (2001) · Chest · doi:10.1378/chest.119.1_suppl.176s · Cited by 2,042
Antithrombotic Therapy for Venous Thromboembolic Disease
Kearon, C., Kahn, S. R., Agnelli, G., Goldhaber, S., Raskob, G. E., & Comerota, A. J. (2008) · Chest · doi:10.1378/chest.08-0658 · Cited by 1,996
Ortel, T. L., Neumann, I., Ageno, W., Beyth, R., Clark, N. P., Cuker, A., Hutten, B. A., Jaff, M. R., Manja, V., Schulman, S., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020001830 · Cited by 1,489
“Summary of the evidence We identified 29 systematic reviews(151-179) and 26 RCTs (n 5 2787).(130,180-204) Trials included individuals with an objectively confirmed symptomatic PE.”
BackgroundAntithrombotic Therapy for Venous Thromboembolic Disease
Büller, H. R., Agnelli, G., Hull, R. D., Hyers, T. M., Prins, M. H., & Raskob, G. E. (2004) · Chest · doi:10.1378/chest.126.3_suppl.401s · Cited by 1,249
Natural History of Venous Thromboembolism
Kearon, C. (2003) · Circulation · doi:10.1161/01.cir.0000078464.82671.78 · Cited by 1,048
Antithrombotic Therapy for VTE Disease
Stevens, S. M., Woller, S. C., Kreuziger, L. B., Bounameaux, H., Doerschug, K., Geersing, G.-J., Huisman, M. V., Kearon, C., King, C. S., Knighton, A. J., et al. (2021) · Chest · doi:10.1016/j.chest.2021.07.055 · Cited by 1,043
Chatterjee, S., Chakraborty, A., Weinberg, I., Kadakia, M., Wilensky, R. L., Sardar, P., Kumbhani, D. J., Mukherjee, D., Jaff, M. R., & Giri, J. (2014) · JAMA · doi:10.1001/jama.2014.5990 · Cited by 818
Wood, K. E. (2002) · Chest · doi:10.1378/chest.121.3.877 · Cited by 718
Guidelines on diagnosis and management of acute pulmonary embolism
(2000) · European Heart Journal · doi:10.1053/euhj.2000.2250 · Cited by 645
Wan, S., Quinlan, D. J., Agnelli, G., & Eikelboom, J. W. (2004) · Circulation · doi:10.1161/01.cir.0000137826.09715.9c · Cited by 616
Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis
Marti, C., John, G., Konstantinides, S., Combescure, C., Sanchez, O., Lankeit, M., Meyer, G., & Perrier, A. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehu218 · Cited by 605
Dalla-Volta, S., Palla, A., Santolicandro, A., Giuntini, C., Pengo, V., Visioli, O., Zonzin, P., Zanuttini, D., Barbaresi, F., Agnelli, G., et al. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90002-5 · Cited by 379
Thrombolytic Therapy in Unstable Patients with Acute Pulmonary Embolism: Saves Lives but Underused
Stein, P. D., & Matta, F. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.10.015 · Cited by 293
Pulmonary Embolism: What have We Learned Since Virchow?
Dalen, J. E. (2002) · Chest · doi:10.1378/chest.122.4.1440 · Cited by 293
Thrombolytic Therapy for Pulmonary Embolism
Kanter, D. S., Mikkola, K. M., Patel, S. R., Parker, J. A., & Goldhaber, S. Z. (1997) · Chest · doi:10.1378/chest.111.5.1241 · Cited by 275
Metadata
- Authors
- Levine, M., Hirsh, J., Weitz, J., Cruickshank, M., Neemeh, J., Turpie, A. G., & Gent, M.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 1990-12
- Volume
- 98
- Issue
- 6
- Pages
- 1473-1479
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W2041176958
- Cited by
- 308
- References
- 27
- FWCI
- 9.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.